Biomarkers: Diabetes, Endocrinology and obesity

Molecular Biomarkers is demarcated as a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacological responses to a pharmaceutical intervention. Biomarkers play an important part in leading clinical trials and treating patients. Advances in molecular diagnostics facilitate medical professionals make knowledgeable, scientifically valid choices. Procedural improvements from different fields, especially cancer, are beginning to show the method towards better models of diabetes pathogenesis and also molecular biomarker discovery. Diabetes is a major lifestyle disease and a leading cause of cardiovascular diseases. It is necessary to identify the potential of biomarkers associated with diabetes for the early detection of the disease and its proper management. Elevated blood pressure, elevated triglycerides, and low HDL cholesterol are some of the common biomarkers of diabetes, adiponectin, C-reactive protein (CRP), interleukin-2 receptor, ferritin  A being the other counterparts. Apart from these available and the known biomarkers, other potential biomarkers are also being searched and reported by researchers.

  • Diabetes Mellitus: RBS, FBS, HbA1c, Retinal assessments
  • Hypertension: BP, HR, Angiotensin I, II, Plasma Renin, Aldosterone
  • Heart Failure: PRO-BNP
  • Asthma/COPD: PFTs, Leukotrienes
  • Cardiac Ischemia: Troponins, Myoglobins
  • Endocrine Biomarkers: LCN2 (NGAL), HAVCR1 (KIM-1), HAMP (Hepcidin), GIP, PDGFB, PGF (PLGF), FLT1 (VEGFR1), FGF23, PYY, CCL2 (MCP1)

 

  • Diabetes Mellitus: RBS, FBS, HbA1c, Retinal assessments
  • Hypertension: BP, HR, Angiotensin I, II, Plasma Renin, Aldosterone
  • Heart Failure: PRO-BNP
  • Asthma/COPD: PFTs, Leukotrienes
  • Cardiac Ischemia: Troponins, Myoglobins
  • Endocrine Biomarkers: LCN2 (NGAL), HAVCR1 (KIM-1)

Related Conference of Biomarkers: Diabetes, Endocrinology and obesity

November 11-12, 2019

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
December 04-05, 2019

3rd Annual Congress on Diabetes and Its Complications

Tokyo, Japan
December 9,10,2019

International Congress and Expo on Diabetic Care

Bangkok,Thailand
December 12-13, 2019

Annual Congress on Diabetes and Endocrinology

Dubai, UAE
January 27-28, 2020

Global Summit On Diabetes & Endocrinology

Bangkok, Thailand
March 25-26, 2020

29th World Diabetes & Heart Congress

| Radisson Narita | Tokyo, Japan
March 27-28, 2020

Annual Summit on Metabolomics

Amsterdam, Netherlands
April 17-18, 2020

3rd Global Meeting on Diabetes and Endocrinology

Kualalumpur, Malaysia
June 15-16, 2020

29thEuropean Diabetes Congress

| Barcelona, Spain
August 17-18, 2020

16th World Congress on Endocrinology & Diabetes

| Copenhagen, Denmark
November 16-17, 2020

2nd Asia Pacific Diabetes and Endocrinology Congress

Brisbane, Australia
June 14-15, 2021

diabetic 2021

Abu Dhabi, UAE

Biomarkers: Diabetes, Endocrinology and obesity Conference Speakers

Recommended Sessions

Related Journals

Are you interested in